# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5252376 | F | Antibacterial activity against Escherichia coli R477-100 assessed as bacterial growth inhibition by CLSI protocol based double-microdilution method | Escherichia coli | 9 | organism-based format | Scientific Literature | ||
2. | ALA5252377 | F | Antibacterial activity against Bacillus subtilis ATCC 6633 assessed as bacterial growth inhibition by CLSI protocol based double-microdilution method | Bacillus subtilis | 9 | organism-based format | Scientific Literature | ||
3. | ALA5252378 | B | Inhibition of prokaryotic circular pBESTluc plasmid DNA from Escherichia coli S30 assessed as inhibition of translation activity by measuring luciferase activity incubated for 60 mins by fluorescence microplate reader analysis | Escherichia coli | 9 | nucleic acid format | Scientific Literature | ||
4. | ALA5252379 | B | Inhibition of eukaryotic luciferase T7 plasmid DNA (unknown origin) assessed as inhibition of protein translation activity by measuring luciferase activity incubated for 60 mins by fluorescence microplate reader analysis | Not specified | 9 | assay format | Scientific Literature | ||
5. | ALA5252380 | B | Selectivity ratio of IC50 for inhibition of eukaryotic luciferase T7 plasmid DNA (unknown origin) assessed as inhibition of protein translation activity to IC50 for inhibition of prokaryotic circular pBESTluc plasmid DNA from Escherichia coli S30 assessed as inhibition of protein translation activity | 9 | assay format | Scientific Literature | |||
6. | ALA5252381 | B | Inhibition of Usher-1 syndrome artificial pR3X plasmid DNA construct assessed as suppression of premature termination codon and measured after 90 mins by Dual luciferase readthrough assay | 5 | nucleic acid format | Scientific Literature |